2024 Q4 Form 10-Q Financial Statement

#000004501224000063 Filed on November 07, 2024

View on sec.gov

Income Statement

Concept 2024 Q4 2024 Q3
Revenue $5.697B
YoY Change -1.84%
Cost Of Revenue $4.627B
YoY Change -1.26%
Gross Profit $1.070B
YoY Change -4.29%
Gross Profit Margin 18.78%
Selling, General & Admin $55.00M
YoY Change -5.17%
% of Gross Profit 5.14%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $270.0M
YoY Change 5.47%
% of Gross Profit 25.23%
Operating Expenses $4.826B
YoY Change 5858.02%
Operating Profit $871.0M
YoY Change -16.01%
Interest Expense -$85.00M
YoY Change -8.6%
% of Operating Profit -9.76%
Other Income/Expense, Net -$52.00M
YoY Change 85.71%
Pretax Income $734.0M
YoY Change -19.87%
Income Tax $154.0M
% Of Pretax Income 20.98%
Net Earnings $571.0M
YoY Change -20.25%
Net Earnings / Revenue 10.02%
Basic Earnings Per Share $650.0K
Diluted Earnings Per Share $650.0K
COMMON SHARES
Basic Shares Outstanding 878.5M shares 882.8M shares
Diluted Shares Outstanding 881.0M shares

Balance Sheet

Concept 2024 Q4 2024 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $2.178B
YoY Change 6.97%
Cash & Equivalents $2.178B
Short-Term Investments
Other Short-Term Assets $1.332B
YoY Change 20.65%
Inventory $3.194B
Prepaid Expenses
Receivables $5.339B
Other Receivables $0.00
Total Short-Term Assets $12.04B
YoY Change 3.82%
LONG-TERM ASSETS
Property, Plant & Equipment $4.945B
YoY Change 4.48%
Goodwill $2.838B
YoY Change -0.42%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $2.058B
YoY Change 20.35%
Total Long-Term Assets $13.29B
YoY Change 3.47%
TOTAL ASSETS
Total Short-Term Assets $12.04B
Total Long-Term Assets $13.29B
Total Assets $25.33B
YoY Change 3.64%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $3.009B
YoY Change -7.07%
Accrued Expenses $941.0M
YoY Change -23.06%
Deferred Revenue
YoY Change
Short-Term Debt $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $5.460B
YoY Change 0.76%
LONG-TERM LIABILITIES
Long-Term Debt $7.639B
YoY Change -1.85%
Other Long-Term Liabilities $683.0M
YoY Change -13.54%
Total Long-Term Liabilities $683.0M
YoY Change -13.54%
TOTAL LIABILITIES
Total Short-Term Liabilities $5.460B
Total Long-Term Liabilities $683.0M
Total Liabilities $14.98B
YoY Change -1.8%
SHAREHOLDERS EQUITY
Retained Earnings $13.87B
YoY Change 15.37%
Common Stock $2.700B
YoY Change 0.41%
Preferred Stock
YoY Change
Treasury Stock (at cost) $5.940B
YoY Change 11.44%
Treasury Stock Shares
Shareholders Equity $10.30B
YoY Change
Total Liabilities & Shareholders Equity $25.33B
YoY Change 3.64%

Cashflow Statement

Concept 2024 Q4 2024 Q3
OPERATING ACTIVITIES
Net Income $571.0M
YoY Change -20.25%
Depreciation, Depletion And Amortization $270.0M
YoY Change 5.47%
Cash From Operating Activities $841.0M
YoY Change -3.78%
INVESTING ACTIVITIES
Capital Expenditures $339.0M
YoY Change -17.11%
Acquisitions
YoY Change
Other Investing Activities -$97.00M
YoY Change 410.53%
Cash From Investing Activities -$436.0M
YoY Change 1.87%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -347.0M
YoY Change -28.16%
NET CHANGE
Cash From Operating Activities 841.0M
Cash From Investing Activities -436.0M
Cash From Financing Activities -347.0M
Net Change In Cash 58.00M
YoY Change -256.76%
FREE CASH FLOW
Cash From Operating Activities $841.0M
Capital Expenditures $339.0M
Free Cash Flow $502.0M
YoY Change 7.96%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Central Index Key
EntityCentralIndexKey
0000045012
dei Document Period End Date
DocumentPeriodEndDate
2024-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-03492
dei Entity Registrant Name
EntityRegistrantName
HALLIBURTON COMPANY
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
75-2677995
dei Entity Address Address Line1
EntityAddressAddressLine1
3000 North Sam Houston Parkway East,
dei Entity Address City Or Town
EntityAddressCityOrTown
Houston,
dei Entity Address State Or Province
EntityAddressStateOrProvince
TX
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
77032
dei City Area Code
CityAreaCode
281
dei Local Phone Number
LocalPhoneNumber
871-2699
dei Security12b Title
Security12bTitle
Common Stock, par value $2.50 per share
dei Trading Symbol
TradingSymbol
HAL
dei Security Exchange Name
SecurityExchangeName
NYSE
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2024Q3 hal Saps4 Upgrade Expense
SAPS4UpgradeExpense
28000000 usd
CY2023Q3 hal Saps4 Upgrade Expense
SAPS4UpgradeExpense
23000000 usd
hal Saps4 Upgrade Expense
SAPS4UpgradeExpense
91000000 usd
hal Saps4 Upgrade Expense
SAPS4UpgradeExpense
36000000 usd
CY2024Q3 us-gaap Costs And Expenses
CostsAndExpenses
4826000000 usd
CY2023Q3 us-gaap Costs And Expenses
CostsAndExpenses
4767000000 usd
us-gaap Costs And Expenses
CostsAndExpenses
14444000000 usd
us-gaap Costs And Expenses
CostsAndExpenses
14254000000 usd
CY2024Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
871000000 usd
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
1037000000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
2890000000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
3025000000 usd
CY2024Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
28000000 usd
CY2023Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
24000000 usd
us-gaap Investment Income Interest
InvestmentIncomeInterest
72000000 usd
us-gaap Investment Income Interest
InvestmentIncomeInterest
59000000 usd
CY2024Q3 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-85000000 usd
CY2023Q3 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-94000000 usd
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-269000000 usd
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-297000000 usd
CY2024Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
5697000000 usd
CY2023Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
5804000000 usd
dei Entity Small Business
EntitySmallBusiness
false
dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2024Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
5697000000 usd
CY2023Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
5804000000 usd
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
17334000000 usd
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
17279000000 usd
CY2024Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
55000000 usd
CY2024Q3 us-gaap Restructuring Settlement And Impairment Provisions
RestructuringSettlementAndImpairmentProvisions
116000000 usd
CY2023Q3 us-gaap Restructuring Settlement And Impairment Provisions
RestructuringSettlementAndImpairmentProvisions
0 usd
us-gaap Restructuring Settlement And Impairment Provisions
RestructuringSettlementAndImpairmentProvisions
116000000 usd
us-gaap Restructuring Settlement And Impairment Provisions
RestructuringSettlementAndImpairmentProvisions
0 usd
CY2023Q1 us-gaap Stockholders Equity Other
StockholdersEquityOther
3000000 usd
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
8445000000 usd
CY2023Q2 us-gaap Profit Loss
ProfitLoss
616000000 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
1000000 usd
CY2023Q2 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.16
CY2023Q2 us-gaap Dividends Common Stock
DividendsCommonStock
144000000 usd
dei Document Type
DocumentType
10-Q
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-180000000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-96000000 usd
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
916000000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
2441000000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
2528000000 usd
CY2024Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
154000000 usd
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
192000000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
539000000 usd
CY2024Q3 us-gaap Profit Loss
ProfitLoss
580000000 usd
CY2023Q3 us-gaap Profit Loss
ProfitLoss
724000000 usd
CY2024Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
878501985 shares
CY2024Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
878501985 shares
CY2023Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
58000000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
178000000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
166000000 usd
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Amendment Flag
AmendmentFlag
false
CY2024Q3 hal Gain Loss On Blue Chip Swap Transactions
GainLossOnBlueChipSwapTransactions
0 usd
CY2023Q3 hal Gain Loss On Blue Chip Swap Transactions
GainLossOnBlueChipSwapTransactions
0 usd
hal Gain Loss On Blue Chip Swap Transactions
GainLossOnBlueChipSwapTransactions
0 usd
hal Gain Loss On Blue Chip Swap Transactions
GainLossOnBlueChipSwapTransactions
104000000 usd
CY2024Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-52000000 usd
CY2023Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-27000000 usd
CY2024Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
734000000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
533000000 usd
us-gaap Profit Loss
ProfitLoss
1902000000 usd
us-gaap Profit Loss
ProfitLoss
1995000000 usd
CY2024Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
9000000 usd
CY2023Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
8000000 usd
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
16000000 usd
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
18000000 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
571000000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
716000000 usd
us-gaap Net Income Loss
NetIncomeLoss
1886000000 usd
us-gaap Net Income Loss
NetIncomeLoss
1977000000 usd
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
650000
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
800000
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2130000
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2190000
CY2024Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
650000
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
790000
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2130000
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2190000
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
881000000 shares
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
898000000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
885000000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
901000000 shares
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
881000000 shares
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
902000000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
886000000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
904000000 shares
CY2024Q3 us-gaap Profit Loss
ProfitLoss
580000000 usd
CY2023Q3 us-gaap Profit Loss
ProfitLoss
724000000 usd
us-gaap Profit Loss
ProfitLoss
1902000000 usd
us-gaap Profit Loss
ProfitLoss
1995000000 usd
CY2024Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
3000000 usd
CY2023Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
1000000 usd
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
3000000 usd
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
3000000 usd
CY2024Q3 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
583000000 usd
CY2023Q3 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
725000000 usd
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
1905000000 usd
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
1998000000 usd
CY2024Q3 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
9000000 usd
CY2023Q3 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
8000000 usd
us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
17000000 usd
us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
18000000 usd
CY2024Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
574000000 usd
CY2023Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
717000000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
1888000000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
1980000000 usd
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2178000000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2264000000 usd
CY2024Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
756000000 usd
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
742000000 usd
CY2024Q3 us-gaap Receivables Net Current
ReceivablesNetCurrent
5339000000 usd
CY2023Q4 us-gaap Receivables Net Current
ReceivablesNetCurrent
4860000000 usd
CY2024Q3 us-gaap Inventory Net
InventoryNet
3194000000 usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
3226000000 usd
CY2024Q3 us-gaap Other Assets Current
OtherAssetsCurrent
1332000000 usd
CY2023Q4 us-gaap Other Assets Current
OtherAssetsCurrent
1193000000 usd
CY2024Q3 us-gaap Assets Current
AssetsCurrent
12043000000 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
11543000000 usd
CY2024Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
12431000000 usd
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
12064000000 usd
CY2024Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
4945000000 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
4900000000 usd
CY2024Q3 us-gaap Goodwill
Goodwill
2838000000 usd
CY2023Q4 us-gaap Goodwill
Goodwill
2850000000 usd
CY2024Q3 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
2446000000 usd
CY2023Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
2505000000 usd
CY2024Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
1001000000 usd
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
1088000000 usd
CY2024Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
2058000000 usd
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1797000000 usd
CY2024Q3 us-gaap Assets
Assets
25331000000 usd
CY2023Q4 us-gaap Assets
Assets
24683000000 usd
CY2024Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
3009000000 usd
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
3147000000 usd
CY2024Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
690000000 usd
CY2023Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
689000000 usd
CY2024Q3 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
482000000 usd
CY2023Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
390000000 usd
CY2024Q3 us-gaap Accrual For Taxes Other Than Income Taxes Current
AccrualForTaxesOtherThanIncomeTaxesCurrent
281000000 usd
CY2023Q4 us-gaap Accrual For Taxes Other Than Income Taxes Current
AccrualForTaxesOtherThanIncomeTaxesCurrent
370000000 usd
CY2024Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
251000000 usd
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
262000000 usd
CY2024Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
747000000 usd
CY2023Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
750000000 usd
CY2024Q3 us-gaap Liabilities Current
LiabilitiesCurrent
5460000000 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
5608000000 usd
CY2024Q3 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
7639000000 usd
CY2023Q4 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
7636000000 usd
CY2024Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
805000000 usd
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
911000000 usd
CY2024Q3 us-gaap Deferred Compensation Liability Classified Noncurrent
DeferredCompensationLiabilityClassifiedNoncurrent
392000000 usd
CY2023Q4 us-gaap Deferred Compensation Liability Classified Noncurrent
DeferredCompensationLiabilityClassifiedNoncurrent
408000000 usd
CY2024Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
683000000 usd
CY2023Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
687000000 usd
CY2024Q3 us-gaap Liabilities
Liabilities
14979000000 usd
CY2023Q4 us-gaap Liabilities
Liabilities
15250000000 usd
CY2024Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
2.50
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
2.50
CY2024Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
2000000000 shares
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
2000000000 shares
CY2024Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
1065000000 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
1065000000 shares
CY2024Q3 us-gaap Common Stock Value
CommonStockValue
2662000000 usd
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
2663000000 usd
CY2024Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
38000000 usd
CY2023Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
63000000 usd
CY2024Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-329000000 usd
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-331000000 usd
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
13865000000 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
12536000000 usd
CY2024Q3 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
187000000 shares
CY2023Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
176000000 shares
CY2024Q3 us-gaap Treasury Stock Value
TreasuryStockValue
5940000000 usd
CY2023Q4 us-gaap Treasury Stock Value
TreasuryStockValue
5540000000 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
10296000000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
9391000000 usd
CY2024Q3 us-gaap Minority Interest
MinorityInterest
56000000 usd
CY2023Q4 us-gaap Minority Interest
MinorityInterest
42000000 usd
CY2024Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
10352000000 usd
CY2023Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
9433000000 usd
CY2024Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
25331000000 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
24683000000 usd
us-gaap Profit Loss
ProfitLoss
1902000000 usd
us-gaap Profit Loss
ProfitLoss
1995000000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
804000000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
742000000 usd
us-gaap Restructuring Settlement And Impairment Provisions
RestructuringSettlementAndImpairmentProvisions
116000000 usd
us-gaap Restructuring Settlement And Impairment Provisions
RestructuringSettlementAndImpairmentProvisions
0 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
516000000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
522000000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-145000000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
137000000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-16000000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
413000000 usd
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-232000000 usd
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-109000000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
2409000000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
2048000000 usd
us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
1016000000 usd
us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
980000000 usd
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
320000000 usd
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
301000000 usd
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
149000000 usd
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
136000000 usd
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
137000000 usd
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
112000000 usd
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
160000000 usd
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
91000000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1210000000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1124000000 usd
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
696000000 usd
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
546000000 usd
us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
452000000 usd
us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
433000000 usd
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
0 usd
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
150000000 usd
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-37000000 usd
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
2000000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-1185000000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-1127000000 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-100000000 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-107000000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-86000000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-310000000 usd
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2264000000 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2346000000 usd
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2178000000 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2036000000 usd
us-gaap Interest Paid Net
InterestPaidNet
336000000 usd
us-gaap Interest Paid Net
InterestPaidNet
355000000 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
369000000 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
528000000 usd
us-gaap Basis Of Accounting
BasisOfAccounting
Basis of Presentation<div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying unaudited condensed consolidated financial statements were prepared using United States generally accepted accounting principles (U.S. GAAP) for interim financial information and the instructions to Form 10-Q and Regulation S-X. Accordingly, these financial statements do not include all information or notes required by U.S. GAAP for annual financial statements and should be read together with our 2023 Annual Report on Form 10-K.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our accounting policies are in accordance with U.S. GAAP. The preparation of financial statements in conformity with these accounting principles requires us to make estimates and assumptions that affect:</span></div><div style="margin-bottom:3pt;padding-left:49.5pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements; and</span></div><div style="padding-left:49.5pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">the reported amounts of revenue and expenses during the reporting period.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Ultimate results could differ from our estimates.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In our opinion, the condensed consolidated financial statements included herein contain all adjustments necessary to present fairly our financial position as of September 30, 2024, the results of our operations for the three and nine months ended September 30, 2024 and 2023, and our cash flows for the nine months ended September 30, 2024 and 2023. Such adjustments are of a normal recurring nature. In addition, certain reclassifications of prior period balances have been made to conform to the current period presentation.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The results of our operations for the three and nine months ended September 30, 2024 may not be indicative of results for the full year.</span></div>
CY2024Q3 us-gaap Severance Costs1
SeveranceCosts1
63000000 usd
us-gaap Severance Costs1
SeveranceCosts1
63000000 usd
CY2024Q3 us-gaap Impairment Charge On Reclassified Assets
ImpairmentChargeOnReclassifiedAssets
49000000 usd
us-gaap Impairment Charge On Reclassified Assets
ImpairmentChargeOnReclassifiedAssets
49000000 usd
CY2024Q3 hal Cybersecurity Incident
CybersecurityIncident
35000000 usd
hal Cybersecurity Incident
CybersecurityIncident
35000000 usd
CY2024Q3 us-gaap Gain Loss On Investments
GainLossOnInvestments
-43000000 usd
us-gaap Gain Loss On Investments
GainLossOnInvestments
-43000000 usd
CY2024Q3 us-gaap Other Restructuring Costs
OtherRestructuringCosts
12000000 usd
us-gaap Other Restructuring Costs
OtherRestructuringCosts
12000000 usd
CY2024Q3 us-gaap Restructuring Settlement And Impairment Provisions
RestructuringSettlementAndImpairmentProvisions
116000000 usd
us-gaap Restructuring Settlement And Impairment Provisions
RestructuringSettlementAndImpairmentProvisions
116000000 usd
CY2024Q3 us-gaap Restructuring Settlement And Impairment Provisions
RestructuringSettlementAndImpairmentProvisions
116000000 usd
us-gaap Restructuring Settlement And Impairment Provisions
RestructuringSettlementAndImpairmentProvisions
116000000 usd
CY2024Q3 us-gaap Severance Costs1
SeveranceCosts1
63000000 usd
CY2024Q3 us-gaap Impairment Charge On Reclassified Assets
ImpairmentChargeOnReclassifiedAssets
49000000 usd
CY2024Q3 hal Cybersecurity Incident
CybersecurityIncident
35000000 usd
CY2024Q3 us-gaap Gain Loss On Investments
GainLossOnInvestments
-43000000 usd
us-gaap Restructuring Settlement And Impairment Provisions
RestructuringSettlementAndImpairmentProvisions
0 usd
CY2023Q3 us-gaap Restructuring Settlement And Impairment Provisions
RestructuringSettlementAndImpairmentProvisions
0 usd
CY2024Q3 hal Number Of Business Segments
NumberOfBusinessSegments
2 division
CY2024Q3 hal Number Of Business Segments
NumberOfBusinessSegments
2 division
CY2024Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
5697000000 usd
CY2023Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
5804000000 usd
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
17334000000 usd
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
17279000000 usd
CY2024Q3 hal Saps4 Upgrade Expense
SAPS4UpgradeExpense
28000000 usd
CY2023Q3 hal Saps4 Upgrade Expense
SAPS4UpgradeExpense
23000000 usd
hal Saps4 Upgrade Expense
SAPS4UpgradeExpense
91000000 usd
hal Saps4 Upgrade Expense
SAPS4UpgradeExpense
36000000 usd
CY2024Q3 us-gaap Restructuring Settlement And Impairment Provisions
RestructuringSettlementAndImpairmentProvisions
116000000 usd
CY2023Q3 us-gaap Restructuring Settlement And Impairment Provisions
RestructuringSettlementAndImpairmentProvisions
0 usd
us-gaap Restructuring Settlement And Impairment Provisions
RestructuringSettlementAndImpairmentProvisions
116000000 usd
us-gaap Restructuring Settlement And Impairment Provisions
RestructuringSettlementAndImpairmentProvisions
0 usd
CY2024Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
871000000 usd
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
1037000000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
2890000000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
3025000000 usd
CY2024Q3 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-85000000 usd
CY2023Q3 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-94000000 usd
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-269000000 usd
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-297000000 usd
CY2024Q3 hal Gain Loss On Blue Chip Swap Transactions
GainLossOnBlueChipSwapTransactions
0 usd
CY2023Q3 hal Gain Loss On Blue Chip Swap Transactions
GainLossOnBlueChipSwapTransactions
0 usd
hal Gain Loss On Blue Chip Swap Transactions
GainLossOnBlueChipSwapTransactions
0 usd
hal Gain Loss On Blue Chip Swap Transactions
GainLossOnBlueChipSwapTransactions
104000000 usd
CY2024Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-52000000 usd
CY2023Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-27000000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-180000000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-96000000 usd
CY2024Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
734000000 usd
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
916000000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
2441000000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
2528000000 usd
hal Gain Loss On Blue Chip Swap Transactions
GainLossOnBlueChipSwapTransactions
104000000 usd
hal Argentina Investment Impairment And Egypt Devaluation
ArgentinaInvestmentImpairmentAndEgyptDevaluation
82000000 usd
CY2024Q3 hal Number Of Business Segments
NumberOfBusinessSegments
2 division
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
17334000000 usd
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
17279000000 usd
CY2024Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
5697000000 usd
CY2023Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
5804000000 usd
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
17334000000 usd
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
17279000000 usd
us-gaap Revenue Performance Obligation Description Of Timing
RevenuePerformanceObligationDescriptionOfTiming
one year
CY2024Q3 hal Number Of Customers Exceed Receivables Threshold
NumberOfCustomersExceedReceivablesThreshold
0 customers
CY2023Q4 hal Number Of Customers Exceed Receivables Threshold
NumberOfCustomersExceedReceivablesThreshold
0 customers
CY2024Q3 hal Maximum Percentage Gross Trade Receivables From One Customer
MaximumPercentageGrossTradeReceivablesFromOneCustomer
0.10
CY2023Q4 hal Maximum Percentage Gross Trade Receivables From One Customer
MaximumPercentageGrossTradeReceivablesFromOneCustomer
0.10
CY2024Q3 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
1987000000 usd
CY2023Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
2069000000 usd
CY2024Q3 us-gaap Inventory Raw Materials And Supplies
InventoryRawMaterialsAndSupplies
1063000000 usd
CY2023Q4 us-gaap Inventory Raw Materials And Supplies
InventoryRawMaterialsAndSupplies
1021000000 usd
CY2024Q3 us-gaap Inventory Work In Process
InventoryWorkInProcess
144000000 usd
CY2023Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
136000000 usd
CY2024Q3 us-gaap Inventory Net
InventoryNet
3194000000 usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
3226000000 usd
CY2024Q3 us-gaap Supplier Finance Program Payment Timing Period
SupplierFinanceProgramPaymentTimingPeriod
P90D
CY2024Q3 hal Outstanding Supplier Finance Payment Obligation
OutstandingSupplierFinancePaymentObligation
321000000 usd
CY2023Q4 hal Outstanding Supplier Finance Payment Obligation
OutstandingSupplierFinancePaymentObligation
322000000 usd
CY2024Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
154000000 usd
CY2024Q3 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
41000000 usd
CY2024Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
734000000 usd
CY2024Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.210
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
192000000 usd
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
916000000 usd
CY2023Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.210
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
539000000 usd
us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
41000000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
2400000000 usd
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.221
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
533000000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
2500000000 usd
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.211
CY2024Q3 hal A2016 Baker Hughes Merger Termination Fee
A2016BakerHughesMergerTerminationFee
3500000000 usd
CY2023Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
9433000000 usd
CY2024Q1 us-gaap Profit Loss
ProfitLoss
609000000 usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
0 usd
CY2024Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.17
CY2024Q1 us-gaap Dividends Common Stock
DividendsCommonStock
151000000 usd
CY2024Q1 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
250000000 usd
CY2024Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
41000000 usd
CY2024Q1 us-gaap Stockholders Equity Other
StockholdersEquityOther
0 usd
CY2024Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
9682000000 usd
CY2024Q2 us-gaap Profit Loss
ProfitLoss
713000000 usd
CY2024Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
0 usd
CY2024Q2 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.17
CY2024Q2 us-gaap Dividends Common Stock
DividendsCommonStock
151000000 usd
CY2024Q2 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
250000000 usd
CY2024Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
56000000 usd
CY2024Q2 us-gaap Stockholders Equity Other
StockholdersEquityOther
4000000 usd
CY2024Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
10046000000 usd
CY2024Q3 us-gaap Profit Loss
ProfitLoss
580000000 usd
CY2024Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
3000000 usd
CY2024Q3 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.17
CY2024Q3 us-gaap Dividends Common Stock
DividendsCommonStock
150000000 usd
CY2024Q3 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
196000000 usd
CY2024Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
68000000 usd
CY2024Q3 us-gaap Stockholders Equity Other
StockholdersEquityOther
-1000000 usd
CY2024Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
10352000000 usd
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
7977000000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
655000000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
1000000 usd
CY2023Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.16
CY2023Q1 us-gaap Dividends Common Stock
DividendsCommonStock
145000000 usd
CY2023Q1 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
100000000 usd
CY2023Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
60000000 usd
CY2023Q2 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
250000000 usd
CY2023Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
61000000 usd
CY2023Q2 us-gaap Stockholders Equity Other
StockholdersEquityOther
2000000 usd
CY2023Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
8727000000 usd
CY2023Q3 us-gaap Profit Loss
ProfitLoss
724000000 usd
CY2023Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
1000000 usd
CY2023Q3 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.16
CY2023Q3 us-gaap Dividends Common Stock
DividendsCommonStock
144000000 usd
CY2023Q3 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
200000000 usd
CY2023Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
84000000 usd
CY2023Q3 us-gaap Stockholders Equity Other
StockholdersEquityOther
3000000 usd
CY2023Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
9189000000 usd
CY2024Q3 us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
6200000 shares
CY2024Q3 us-gaap Stock Repurchase Program Remaining Authorized Repurchase Amount1
StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
3400000000 usd
CY2024Q3 hal Treasury Stock Shares Acquired From Inception
TreasuryStockSharesAcquiredFromInception
273000000 shares
CY2024Q3 hal Treasury Stock Value Acquired Cost Method From Inception
TreasuryStockValueAcquiredCostMethodFromInception
10800000000 usd
CY2023Q3 us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
5100000 shares
CY2024Q3 us-gaap Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
-82000000 usd
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
-84000000 usd
CY2024Q3 us-gaap Accumulated Other Comprehensive Income Loss Defined Benefit Pension And Other Postretirement Plans Net Of Tax
AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax
209000000 usd
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Defined Benefit Pension And Other Postretirement Plans Net Of Tax
AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax
207000000 usd
CY2024Q3 hal Accumulated Other Comprehensive Income Loss Other Net Of Tax
AccumulatedOtherComprehensiveIncomeLossOtherNetOfTax
-38000000 usd
CY2023Q4 hal Accumulated Other Comprehensive Income Loss Other Net Of Tax
AccumulatedOtherComprehensiveIncomeLossOtherNetOfTax
-40000000 usd
CY2024Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-329000000 usd
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-331000000 usd
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
881000000 shares
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
898000000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
885000000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
901000000 shares
CY2024Q3 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0 shares
CY2023Q3 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
4000000 shares
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
1000000 shares
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
3000000 shares
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
881000000 shares
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
902000000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
886000000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
904000000 shares
hal Numberofdaysfromperiodend
Numberofdaysfromperiodend
P2D
hal Numberofdaysfromperiodend
Numberofdaysfromperiodend
P2D

Files In Submission

Name View Source Status
0000045012-24-000063-index-headers.html Edgar Link pending
0000045012-24-000063-index.html Edgar Link pending
0000045012-24-000063.txt Edgar Link pending
0000045012-24-000063-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
hal-20240930.htm Edgar Link pending
hal-20240930.xsd Edgar Link pending
hal-20240930_g1.jpg Edgar Link pending
hal-20240930_g2.jpg Edgar Link pending
hal-20240930_g3.jpg Edgar Link pending
hal_09302024-ex311.htm Edgar Link pending
hal_09302024-ex312.htm Edgar Link pending
hal_09302024-ex321.htm Edgar Link pending
hal_09302024-ex322.htm Edgar Link pending
hal_09302024-ex95.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
hal-20240930_lab.xml Edgar Link unprocessable
hal-20240930_pre.xml Edgar Link unprocessable
hal-20240930_htm.xml Edgar Link completed
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
hal-20240930_def.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
hal-20240930_cal.xml Edgar Link unprocessable